Indication
Sleep Syncope
1 clinical trial
2 products
Clinical trial
Randomized, Prospective, Placebo-Controlled, Crossover Study of Ondansetron in the Prevention of Sleep Syncope: The Nineth Prevention of Syncope Trial (POST9)Status: Not yet recruiting, Estimated PCD: 2026-12-31
Product
OndansetronProduct
Matching placebo